Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EXEL | EXELIXIS, INC. | Feb 14, 2025 | 4 | -$226K | 4 | Feb 19, 2025 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
EXEL | EXELIXIS, INC. | May 31, 2024 | 1 | $0 | 4 | Jun 4, 2024 | Director |
EXEL | EXELIXIS, INC. | Jan 5, 2024 | 2 | $0 | 4 | Jan 9, 2024 | Director |
EXEL | EXELIXIS, INC. | Jan 5, 2024 | 0 | $0 | 3 | Jan 9, 2024 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Sep 16, 2022 | 2 | $0 | 4 | Sep 19, 2022 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |